NanoViricides to Present at the Spartan Capital Investor Conference 2025 in New York City Today, November 3rd

Core Viewpoint - NanoViricides, Inc. is a clinical stage company focused on developing broad-spectrum antiviral drugs that are designed to be effective against viruses without the risk of escape [1] Group 1 - The company will present at the Spartan Capital Investor Conference 2025 in New York City [1] - The presentation is scheduled for November 3, 2025, at 09:45 am ET [1] - The event will take place at the Marriott Marquis Hotel, New York, NY [1]